본문 바로가기
KERD
논문KCI 등재

Invasive strategies for rhythm control of atrial fibrillation: a narrative review

김홍주|Chan-Hee Lee
영남대학교 의과대학 (Yeungnam University College of Medicine)|2024.10|Journal of Yeungnam Medical Science|제41권 제4호|pp. 279-287|DOI 10.12701/jyms.2024.00703

3

조회

0

다운로드

0

인용

0

참고문헌

키워드

Atrial fibrillationRadiofrequency ablationCatheter ablationCryosurgeryPulse field ablation
주제분류의학일반

초록

Atrial fibrillation (AF) is the most common sustained tachyarrhythmia and its increasing prevalence has resulted in a growing healthcare burden. A recent landmark randomized trial, the EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial), highlighted the importance of early rhythm control in AF, which was previously underemphasized. Rhythm control therapy includes antiarrhythmic drugs, direct-current cardioversion, and catheter ablation. Currently, catheter ablation is indicated for patients with AF who are either refractory or intolerant to antiarrhythmic drugs or who exhibit decreased left ventricular systolic function. Catheter ablation can be categorized according to the energy source used, including radiofrequency ablation (RFA), cryoablation, laser ablation, and the recently emerging pulsed field ablation (PFA). Catheter ablation techniques can also be divided into the point-by-point ablation method, which ablates the pulmonary vein (PV) antrum one point at a time, and the single-shot technique, which uses a spherical catheter to ablate the PV antrum in a single application. PFA is known to be applicable to both point-by-point and single-shot techniques and is expected to be promising owing to its tissue specificity, resulting in less collateral damage than catheter ablation involving thermal energy, such as RFA and cryoablation. In this review, we aimed to outline catheter ablation for rhythm control in AF by reviewing previous studies.

Abstract

Atrial fibrillation (AF) is the most common sustained tachyarrhythmia and its increasing prevalence has resulted in a growing healthcare burden. A recent landmark randomized trial, the EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial), highlighted the importance of early rhythm control in AF, which was previously underemphasized. Rhythm control therapy includes antiarrhythmic drugs, direct-current cardioversion, and catheter ablation. Currently, catheter ablation is indicated for patients with AF who are either refractory or intolerant to antiarrhythmic drugs or who exhibit decreased left ventricular systolic function. Catheter ablation can be categorized according to the energy source used, including radiofrequency ablation (RFA), cryoablation, laser ablation, and the recently emerging pulsed field ablation (PFA). Catheter ablation techniques can also be divided into the point-by-point ablation method, which ablates the pulmonary vein (PV) antrum one point at a time, and the single-shot technique, which uses a spherical catheter to ablate the PV antrum in a single application. PFA is known to be applicable to both point-by-point and single-shot techniques and is expected to be promising owing to its tissue specificity, resulting in less collateral damage than catheter ablation involving thermal energy, such as RFA and cryoablation. In this review, we aimed to outline catheter ablation for rhythm control in AF by reviewing previous studies.

참고문헌 (93)

  1. Marijon E, "Causes of death and influencing factors in patients with atrial fibrillation : a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study", Circulation, 128, pp.2192~2201 (2013)
  2. Camm AJ, "XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation", Eur Heart J, 37, pp.1145~1153 (2016)
  3. Kim D, "Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015", Heart, 104, pp.2010~2017 (2018)
  4. Bunch TJ, "Atrial fibrillation and dementia", Circulation, 142, pp.618~620 (2020)
  5. Hindricks G, "2020 ESC guideline for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS) : The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC", Eur Heart J, 42, pp.373~498 (2021)
  6. Giannone ME, "Atrial fibrillation and the risk of early-onset dementia : a systematic review and meta-analysis", J Am Heart Assoc, 11, pp.e025653~ (2022)
  7. Roy D, "Rhythm control versus rate control for atrial fibrillation and heart failure", N Engl J Med, 358, pp.2667~2677 (2008)
  8. Opolski G, "Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation : the results of the Polish How to Treat Chronic Atrial Fibrillation(HOT CAFE)Study", Chest, 126, pp.476~486 (2004)
  9. ), "Am J Cardiol", 2003, 468~472
  10. Wyse DG, "A comparison of rate control and rhythm control in patients with atrial fibrillation", N Engl J Med, 347, pp.1825~1833 (2002)
  11. Van Gelder IC, "A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation", N Engl J Med, 347, pp.1834~1840 (2002)
  12. Hohnloser SH, "Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF). A randomised trial", Lancet, 356, pp.1789~1794 (2000)
  13. Kim D, "Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation : nationwide cohort study", BMJ, 373, pp.n991~ (2021)
  14. Kirchhof P, "Early rhythm-control therapy in patients with atrial fibrillation", N Engl J Med, 383, pp.1305~1316 (2020)
  15. Kalman JM, "Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences", Eur Heart J, 44, pp.2447~2454 (2023)
  16. Bunch TJ, "Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes", Heart Rhythm, 10, pp.1257~1262 (2013)
  17. De Greef Y, "Diagnosis-to-ablation time as a predictor of success : early choice for pulmonary vein isolation and long-term outcome in atrial fibrillation : results from the Middelheim-PVI Registry", Europace, 20, pp.589~595 (2018)
  18. Yu HT, "Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation", J Cardiovasc Electrophysiol, 31, pp.457~464 (2020)
  19. De Greef Y, "Impact of diagnosis-to-ablation time on AF recurrence: pronounced the first 3 years, irrelevant thereafter", JACC Clin Electrophysiol, 9, pp.2263~2272 (2023)
  20. Turakhia MP, "Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States", Clin Cardiol, 46, pp.484~493 (2023)
  21. Tsao CW, "Heart disease and stroke statistics: 2023 update. A report from the American Heart Association", Circulation, 147, pp.e93~621 (2023)
  22. Chugh SS, "Worldwide epidemiology of atrial fibrillation : a Global Burden of Disease 2010 Study", Circulation, 129, pp.837~847 (2014)
  23. Kim D, "10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population", Am Heart J, 202, pp.20~26 (2018)
  24. Lloyd-Jones DM, "Lifetime risk for development of atrial fibrillation : the Framingham Heart Study", Circulation, 110, pp.1042~1046 (2004)
  25. Gorenek B, "European Heart Rhythm Association(EHRA)", European Association of Cardiovascular Prevention and Rehabilitation(EACPR)position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society(HRS)and Asia Pacific Heart Rhythm Society(APHRS), 2017, pp.19, 190~225
  26. Miller JD, "Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation", J Am Coll Cardiol, 66, pp.2899~2906 (2015)
  27. January CT, "2014 AHA", ACC, American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2014[DOI]
  28. European Heart Rhythm Association, "Guidelines for the management of atrial fibrillation : the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)", Eur Heart J, 31, pp.2369~2429 (2010)
  29. Benjamin EJ, "Independent risk factors for atrial fibrillation in a population-based cohort", JAMA, 271, pp.840~844 (1994)
  30. Cox JL, "The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure", J Thorac Cardiovasc Surg, 101, pp.569~583 (1991)
  31. Prasad SM, "The Cox maze III procedure for atrial fibrillation : long-term efficacy in patients undergoing lone versus concomitant procedures", J Thorac Cardiovasc Surg, 126, pp.1822~1828 (2003)
  32. Gaynor SL, "Surgical treatment of atrial fibrillation : predictors of late recurrence", J Thorac Cardiovasc Surg, 129, pp.104~111 (2005)
  33. Johansson BI, "Low mortality and low rate of perceived and documented arrhythmias after Cox maze III surgery for atrial fibrillation", Pacing Clin Electrophysiol, 37, pp.147~156 (2014)
  34. Haïssaguerre M, "Electrophysiological breakthroughs from the left atrium to the pulmonary veins", Circulation, 102, pp.2463~2465 (2000)
  35. Haïssaguerre M, "Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins", N Engl J Med, 339, pp.659~666 (1998)
  36. Pappone C, "Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation : efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation", Circulation, 104, pp.2539~2544 (2001)
  37. Pappone C, "Circumferential radiofrequency ablation of pulmonary vein ostia : a new anatomic approach for curing atrial fibrillation", Circulation, 102, pp.2619~2628 (2000)
  38. Verma A, "Approaches to catheter ablation for persistent atrial fibrillation", N Engl J Med, 372, pp.1812~1822 (2015)
  39. He X, "Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation : a meta-analysis", J Interv Card Electrophysiol, 46, pp.267~274 (2016)
  40. Scott PA, "The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation : a meta-analysis", Europace, 18, pp.359~367 (2016)
  41. Lee JM, "The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation", JACC Clin Electrophysiol, 5, pp.1253~1261 (2019)
  42. Kistler PM, "Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation : the CAPLA randomized clinical trial", JAMA, 329, pp.127~135 (2023)
  43. Writing Committee Members, "2023 ACC", AHA, HRS guideline for the diagnosis and management of atrial fibrillation : a report of the American College of Cardiology, pp.American Heart Association Joint Committee on Clinical Practice Guidelines, J Am Coll Cardiol[DOI]
  44. Calkins H, "2017 HRS", EHRA, APHRS, pp.SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, Heart Rhythm[DOI]
  45. Morady F, "Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the Wolff-Parkinson-White syndrome", N Engl J Med, 310, pp.705~707 (1984)
  46. Houmsse M, "Biophysics and clinical utility of irrigated-tip radiofrequency catheter ablation", Expert Rev Med Devices, 9, pp.59~70 (2012)
  47. Natale A, "Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial", J Am Coll Cardiol, 64, pp.647~656 (2014)
  48. Reddy VY, "Relationship between catheter stability and 12-month success after pulmonary vein isolation : a subanalysis of the SMART-AF trial", JACC Clin Electrophysiol, 2, pp.691~699 (2016)
  49. Macle L, "Atrial fibrillation ablation with a spring sensor-irrigated contact force-sensing catheter compared with other ablation catheters : systematic literature review and meta-analysis", BMJ Open, 9, pp.e023775~ (2019)
  50. Duytschaever M, "Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions : the multicentre VISTAX trial", Europace, 22, pp.1645~1652 (2020)
  51. Natale A, "Long-term safety and effectiveness of paroxysmal atrial fibrillation ablation using a porous tip contact force-sensing catheter from the SMART SF trial", J Interv Card Electrophysiol, 61, pp.63~69 (2021)
  52. Habibi M, "Radiofrequency ablation: technological trends, challenges, and opportunities", Europace, 23, pp.511~519 (2021)
  53. Suga K, "Optimal ablation settings of TactiFlex SE laser-cut irrigated-tip catheter : comparison with ThermoCool SmartTouch SurroundFlow porous irrigated-tip catheter", J Interv Card Electrophysiol (2024)[DOI]
  54. Naniwadekar A, "High-power short-duration ablation of atrial fibrillation : a contemporary review", Pacing Clin Electrophysiol, 44, pp.528~540 (2021)
  55. Leshem E, "High-power and short-duration ablation for pulmonary vein isolation : biophysical characterization", JACC Clin Electrophysiol, 4, pp.467~479 (2018)
  56. Baher A, "High-power radiofrequency catheter ablation of atrial fibrillation : using late gadolinium enhancement magnetic resonance imaging as a novel index of esophageal injury", JACC Clin Electrophysiol, 4, pp.1583~1594 (2018)
  57. Ravi V, "High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis", Europace, 23, pp.710~721 (2021)
  58. Osorio J, "Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY trial", JACC Clin Electrophysiol, 9, pp.468~480 (2023)
  59. Hussein AA, "Paroxysmal atrial fibrillation ablation with a novel temperature-controlled CF-sensing catheter : Q-FFICIENCY clinical and healthcare utilization benefits", J Cardiovasc Electrophysiol, 34, pp.2493~2503 (2023)
  60. Andrade JG, "Catheter cryoablation : biology and clinical uses", Circ Arrhythm Electrophysiol, 6, pp.218~227 (2013)
  61. Avitall B, "Cryotherapy of cardiac arrhythmia : from basic science to the bedside", Heart Rhythm, 12, pp.2195~2203 (2015)
  62. Kuck KH, "Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation", N Engl J Med, 374, pp.2235~2245 (2016)
  63. Wazni OM, "Cryoballoon ablation as initial therapy for atrial fibrillation", N Engl J Med, 384, pp.316~324 (2021)
  64. Straube F, "Cryoballoon ablation strategy in persistent atrial fibrillation", Front Cardiovasc Med, 8, pp.758408~ (2021)
  65. Andrade JG, "Cryoablation or drug therapy for initial treatment of atrial fibrillation", N Engl J Med, 384, pp.305~315 (2021)
  66. Su WW, "Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation : results from the multicenter STOP Persistent AF trial", Heart Rhythm, 17, pp.1841~1847 (2020)
  67. Metzner A, "The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon", J Cardiovasc Electrophysiol, 25, pp.466~470 (2014)
  68. Fürnkranz A, "Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients", Europace, 17, pp.574~578 (2015)
  69. Abugattas JP, "Phrenic nerve injury during right inferior pulmonary vein ablation with the second-generation cryoballoon : clinical, procedural, and anatomical characteristics", Europace, 20, pp.e156~e163 (2018)
  70. Hoffmann E, "Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation", Europace, 21, pp.1313~1324 (2019)
  71. Dukkipati SR, "Pulmonary vein isolation using the visually guided laser balloon: a prospective, multicenter, and randomized comparison to standard radiofrequency ablation", J Am Coll Cardiol, 66, pp.1350~1360 (2015)
  72. Bordignon S, "Energy titration strategies with the endoscopic ablation system: lessons from the high-dose vs. low-dose laser ablation study", Europace, 15, pp.685~689 (2013)
  73. Reynolds MR, "Laser balloon ablation for AF : a systematic review and meta-analysis", J Cardiovasc Electrophysiol, 29, pp.1363~1370 (2018)
  74. Weber S, "First results and follow-up of a second-generation circular mapping and ablation catheter", J Interv Card Electrophysiol, 47, pp.213~219 (2016)
  75. Mönnig G, "Multielectrode Pulmonary Vein Ablation Catheter(PVAC(®)) : current data on results and risks", Herzschrittmacherther Elektrophysiol, 25, pp.236~240 (2014)
  76. Gaita F, "Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon", J Cardiovasc Electrophysiol, 22, pp.961~968 (2011)
  77. Bulava A, "Catheter ablation for paroxysmal atrial fibrillation : a randomized comparison between multielectrode catheter and point-by-point ablation", Pacing Clin Electrophysiol, 33, pp.1039~1046 (2010)
  78. Vurma M, "Safety and efficacy of the nMARQ catheter for paroxysmal and persistent atrial fibrillation", Europace, 18, pp.1164~1169 (2016)
  79. Mahida S, "nMARQ ablation for atrial fibrillation : results from a multicenter study", J Cardiovasc Electrophysiol, 26, pp.724~729 (2015)
  80. Shin DI, "Initial results of using a novel irrigated multielectrode mapping and ablation catheter for pulmonary vein isolation", Heart Rhythm, 11, pp.375~383 (2014)
  81. Reddy VY, "A novel visually guided radiofrequency balloon ablation catheter for pulmonary vein isolation : one-year outcomes of the multicenter AF-FICIENT I trial", Circ Arrhythm Electrophysiol, 14, pp.e009308~ (2021)
  82. Dhillon GS, "Use of a multi-electrode radiofrequency balloon catheter to achieve pulmonary vein isolation in patients with paroxysmal atrial fibrillation : 12-month outcomes of the RADIANCE study", J Cardiovasc Electrophysiol, 31, pp.1259~1269 (2020)
  83. Boersma L, "New energy sources and technologies for atrial fibrillation catheter ablation", Europace, 24(Suppl 2), pp.ii44~ii51 (2022)
  84. Maor E, "Pulsed electric fields for cardiac ablation and beyond : a state-of-the-art review", Heart Rhythm, 16, pp.1112~1120 (2019)
  85. Neven K, "Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus", Circ Arrhythm Electrophysiol, 10, pp.e004672~ (2017)
  86. van Driel VJ, "Low vulnerability of the right phrenic nerve to electroporation ablation", Heart Rhythm, 12, pp.1838~1844 (2015)
  87. du Pré BC, "Minimal coronary artery damage by myocardial electroporation ablation", Europace, 15, pp.144~149 (2013)
  88. Ekanem E, "Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)", Europace, 24, pp.1256~1266 (2022)
  89. Reddy VY, "Pulsed field ablation for pulmonary vein isolation in atrial fibrillation", J Am Coll Cardiol, 74, pp.315~326 (2019)
  90. Reddy VY, "Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation", N Engl J Med, 389, pp.1660~1671 (2023)
  91. Duytschaever M, "Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system : 1-year outcomes of the multicenter inspIRE study", Circ Arrhythm Electrophysiol, 16, pp.e011780~ (2023)
  92. Di Biase L, "Pulsed field ablation index-guided ablation for lesion formation : impact of contact force and number of applications in the ventricular model", Circ Arrhythm Electrophysiol, 17, pp.e012717~ (2024)
  93. Di Biase L, "Point-by-point pulsed field ablation using a multimodality generator and a contact force-sensing ablation catheter : comparison with radiofrequency ablation in a remapped chronic swine heart", Circ Arrhythm Electrophysiol, 16, pp.663~671 (2023)

관련 논문AI추천

Role of catheter ablation in patients with heart failure and atrial fibrillationHyoung-Seob Park, Min-Su Jung대한내과학회 · The Korean Journal of Internal Medicine2025 · 제40권 제4호Comparative Efficacy and Procedural Durability of Radiofrequency Ablation for Atrial Fibrillation: A Systematic Review and a Meta-Analysis박소희, 박은철, 지선하, 최현숙한국보건의료기술평가학회 · 보건의료기술평가2015 · 제3권 제1호2021 대한부정맥학회 심방세동 전극도자 및 수술적 절제술 지침심재민, 이지현, 임우현, 정보영대한내과학회 · 대한내과학회지2022 · 제97권 제1호2018 심방세동 카테터 절제술 대한민국 진료지침: Part II김준, 김기훈, 김주연, 노승영, 박형섭, 박희남, 심재민, 오용석, 유희태, 윤남식, 이정명, 정동섭, 조영진대한부정맥학회 · International Journal of Arrhythmia2018 · 제19권 제3호2018 심방세동 카테터 절제술 대한민국 진료지침: Part I김준, 김기훈, 김영훈, 김주연, 노승영, 박형섭, 박희남, 심재민, 유희태, 윤남식, 이정명, 정동섭, 조영진대한부정맥학회 · International Journal of Arrhythmia2018 · 제19권 제3호Endurance Ablation Facilitates Long-lasting Circumferential Pulmonary Vein Isolation and Better Clinical Outcomes in Patients with Paroxysmal Atrial Fibrillation김종윤, 김태훈, 박준범, 박희남, 엄재선, 유희태, 이문형, 정보영대한부정맥학회 · International Journal of Arrhythmia2017 · 제18권 제3호

이 간행물의 다른 논문 (9건)

Postoperative conditions of rehabilitative interest in lung transplantation: a systematic reviewEsra Pehlivan, Massimiliano Polastri, Robert M. Reed, Allaina Edenpp. 235-251Recent updates on classification and unsolved issues of diverticular disease: a narrative reviewKyeong Ok Kimpp. 252-260Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative reviewSeokho Yunpp. 261-268Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative reviewSeung Min Chungpp. 269-278Outcomes in patients with out-of-hospital cardiac arrest according to prehospital advanced airway management timing: a retrospective observational studyHyun Wook Ryoo, Sang-Hun Leepp. 288-295
원문 보기